Ilan Sobel has been the CEO of BioHarvest Sciences since July 2020. Bringing a commercial focus in Go-To-Market planning and execution, Ilan has scaled production capabilities from Research & Development levels up to industrial scale, and is building a biotech company with novel, and even patentable plant-based products that are based on science and backed by clinical trials. Ilan has added the office of Chief Medical Officer, which leads both Clinical Trials and Direct-to-Doctor initiatives. Ilan has worked in diverse global jurisdictions, and is based in Israel. Prior to BioHarvest, Ilan served for 6 years at  Weissbeerger, as both Chief Operating Officer and then Chief Commercial Officer. In this capacity, Ilan played a major leadership role in building a disruptive BIG Data, IOT & Software Company servicing major Beverage players which was ultimately purchased by Anheuser Busch InBev. Previously, Ilan served an 18 year stint as an International Employee of The Coca-Cola Company, where he played a pivotal role in key senior leadership positions generating significant revenue and profit growth and improving brand health trends across diverse global markets.